Aigialomycins and related polyketide metabolites from the mangrove fungus Aigialus parvus BCC 5311

By M. Isaka, Arunrat Yangchum, Sutichai Intamas, K. Kocharin, E. Jones, P. Kongsaeree, Samran Prabpai. 2009

85 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Refined families of Dothideomycetes: Dothideomycetidae and Pleosporomycetidae (2020, background): “Bioactive compounds have been described from Aigialus parvus e.g. aigialomycins A and hypothemycin with antimalarial activity (Isaka et al. 2002).”
Fifty years of marine mycology (2011, background): “All three fungi have been shown to produce bioactive compounds (Abraham et al. 1994; Isaka et al. 2002, 2009).”
Ecological role and biotechnological potential of mangrove fungi: a review (2013, background): “…4- O-demethylhypothemycin (11), and aigialone (12) (Isaka et al. 2002) along with six new nonaketide metabolites such as aigialomycins F (4) and G (5a/5b), 70,80-dihydroaigialospirol (7), 40-deoxy-70,80-dihydroaigialospirol (8), and rearranged macrolides 9 and 10 (Isaka et al. 2009) (Figure 3).”